SkyOak Wealth’s Standard BioTools LAB Stock Holding History

SkyOak Wealth’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-162,643	Closed	-$638K	–	259
2021 Q4	$638K	Sell	162,643 -19,242	-11%	-$90.1K	0.16%	117
2021 Q3	$1.2M	Hold	181,885	–	–	0.32%	74
2021 Q2	$1.12M	Sell	181,885 -3,921	-2%	-$21K	0.3%	76
2021 Q1	$918K	Buy	+185,806	New	+$1.02M	0.26%	86

Other funds holding LAB

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SkyOak Wealth's LAB Position: Q1 2022 in Review

SkyOak Wealth sold out of Standard BioTools (LAB) in Q1 2022, closing a stake of 162,643 shares — an estimated $638K sold.

SkyOak Wealth first reported a position in LAB in Q1 2021 and held it in 4 quarters. The position peaked at $1.2M in Q3 2021. 109 funds tracked by Wall St. Rank hold LAB as of Q1 2022.

SkyOak Wealth reported no remaining Standard BioTools position as of Q1 2022 after selling out during the quarter.
SkyOak Wealth sold 162,643 Standard BioTools shares in Q1 2022, an estimated $638K.
SkyOak Wealth first reported a position in Standard BioTools in Q1 2021 and held it in 4 quarters.
SkyOak Wealth's Standard BioTools position peaked at $1.2M in Q3 2021.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2022.

Based on SkyOak Wealth's 13F filing for Q1 2022, filed 18 Apr 2022.